Yesterday, Jiangbo Pharmaceuticals, Inc. (NASDAQ:JGBO) stock followed its upward direction from the beginning of the week.
The huge volume traded confirmed investors’ willingness to keep JGBO stock price as far as possible from last July’s deep bottom.
The company has not seen news since the beginning of July, which may be a signal that during today’s trading session the third green candlestick for the week may become questionable.
JGBO stock was approved for listing on The Nasdaq Global Market at the beginning of this June. The JGBO symbol is traded on the NASDAQ from June 8, 2010.
Around July 20, JGBO stock plunged at the bottom, almost touching its 52-week low of $7.25 per share.[BANNER]
Up to yesterday, the following quick recovering of JGBO shares provided a price increase of 20.71% from the above tragic for JGBO stock date.
This week, the huge volume traded proved that JGBO stock is looking for the best trading range at the new market and gathers strength to attract more and more investors.
Jiangbo Pharmaceuticals, Inc. is engaged in the development, production and sales of pharmaceutical products in the People’s Republic of China. The company operates through its subsidiary Laiyang Jiangbo Pharmaceuticals Co., Ltd..
JGBO purchases patents for drugs or develops drugs through collaboration with leading research institutions.
